MoneyWorks4Me

Colinz Laboratories - Quaterly Results

31 Oct 2023 Evaluate
The sales is pegged at Rs. 17.86 millions for the September 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 19.17 millions during the year-ago period.Net profit for the quarter ended September 2023 increases to Rs. 1.22  millions from Rs. 1.17 millions.Operating Profit reported a sharp decline to 2.02 millions from 2.12 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 17.86 19.17 -6.83 36.85 37.55 -1.86 71.55 69.74 2.60
Other Income 0.76 0.45 68.89 1.20 0.86 39.53 1.72 1.71 0.58
PBIDT 2.02 2.12 -4.72 3.97 3.99 -0.50 7.80 7.57 3.04
Interest 0.09 0.13 -30.77 0.17 0.25 -32.00 0.52 0.76 -31.58
PBDT 1.93 1.99 -3.02 3.80 3.74 1.60 7.28 6.81 6.90
Depreciation 0.33 0.32 3.13 0.66 0.64 3.13 1.29 2.01 -35.82
PBT 1.60 1.67 -4.19 3.14 3.10 1.29 5.99 4.80 24.79
TAX 0.38 0.50 -24.00 0.71 0.83 -14.46 1.43 1.41 1.42
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.16 -0.09 77.78
PAT 1.22 1.17 4.27 2.43 2.27 7.05 4.56 3.39 34.51
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 35.45 -28.94
PBIDTM(%) 11.31 11.06 2.27 10.77 10.63 1.39 10.90 10.85 0.43
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..